Copyright © 2021. Inderes Oyj. All rights reserved.

Genovis AB

Analyytikko

Sisäpiirin kaupat

Nettovaikuttavuus

Tiedotteet
14.4.
2021

The shareholders of Genovis AB, corporate identity no 556574-5345, are hereby given notice of the Annual General Meeting on Thursday, May 20, 2021.

Tiedotteet
13.4.
2021
Firms Working to Co-Develop Automated Biotherapeutic Characterization Workflows, Combining Genovis SmartEnzymes™ and Waters LC-MS Instrumentation.
  • Collaboration intended to bring speed and simplicity to bio-characterization workflows

  • Automated workflows to cut the time and effort required to monitor critical quality attributes of biotherapeutics in regulated laboratories

  • Waters and Genovis share mutual goal to advance the science behind the analysis of glycoproteins and protein therapeutics

Tiedotteet
29.3.
2021

Genovis AB's (publ) Chief Financial Officer (CFO) Johny Humaloja has resigned from his position to take on new challenges.

Johny has been employed by Genovis since 2019 and he will continue in his current role during the notice period. A process to recruit a new CFO will be initiated immediately.

"During his time at Genovis, Johny has contributed to the development of the Group's financial management. I would like to thank him for his contribution to Genovis and wish him good luck in his new endeavors," says Fredrik Olsson, CEO of Genovis

Tiedotteet
2.3.
2021

The Nomination Committee proposes that Genovis should expand its Board of Directors at the 2021 Annual General Meeting and proposes Steve Jordan to be elected as a new board member.

Tiedotteet
11.2.
2021

Report for the fourth quarter of 2020          

Tiedotteet
10.12.
2020

Genovis AB and Glykos Finland Oy have today entered into a licensing and supply agreement for state-of-the-art linker-payload technologies to be combined with the site-specific antibody conjugation platform offered by Genovis.

Tiedotteet
5.11.
2020
July - September in brief
  • Net sales totaled SEK 14,216 (24,279) thousand.
Tiedotteet
13.8.
2020
April - June in brief
  • Net sales rose by 35 percent to SEK 15,490 (11,509) thousand.
  •  

Genovis AB